Baixar PDF

Outros usuários também visualizaram estes artigos

Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice Carla Boquimpani, Fernanda Salles Seguro, Gustavo Henrique Romani Magalhães, Ingrid Luise Soares Pinto, Israel Bendit, Jaisson André Pagnoncelli Bortolini, Katia Borgia Barbosa Pagnano, Renato Centrone, Vaneuza Funke
10.1016/j.htct.2022.04.002
Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase? T.P. de Almeida Filho, P.A. Maia Filho, Maritza Cavalcante Barbosa, Luana Letícia Alves Dutra, Marilena Facundo de Castro, Fernando Barroso Duarte, Acy Telles de Souza Quixadá, Romélia Pinheiro Gonçalves Lemes
10.1016/j.htct.2018.10.003
Current treatment preferences in acute myeloid leukemia: a survey in Brazil Rodrigo Doyle Portugal, Márcio Luiz Moore Nucci
10.1016/j.htct.2019.07.005